Doug Schenkel
Stock Analyst at Wolfe Research
(4.55)
# 329
Out of 4,415 analysts
42
Total ratings
54.55%
Success rate
34%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Initiates: Outperform | n/a | $123.99 | - | 2 | Dec 13, 2023 | |
| EXAS Exact Sciences | Initiates: Outperform | n/a | $60.54 | - | 4 | Dec 13, 2023 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $571.25 | - | 3 | Dec 13, 2023 | |
| TXG 10x Genomics | Initiates: Outperform | n/a | $26.29 | - | 2 | Dec 13, 2023 | |
| MYGN Myriad Genetics | Initiates: Outperform | n/a | $19.22 | - | 1 | Dec 13, 2023 | |
| BRKR Bruker | Initiates: Outperform | n/a | $70.09 | - | 1 | Dec 13, 2023 | |
| RVTY Revvity | Initiates: Peer Perform | n/a | $101.08 | - | 1 | Dec 13, 2023 | |
| PACB Pacific Biosciences of California | Initiates: Peer Perform | n/a | $1.76 | - | 1 | Dec 13, 2023 | |
| QGEN Qiagen | Initiates: Peer Perform | n/a | $42.68 | - | 1 | Dec 13, 2023 | |
| AVTR Avantor | Initiates: Peer Perform | n/a | $24.32 | - | 1 | Dec 13, 2023 | |
| GH Guardant Health | Initiates: Peer Perform | n/a | $18.58 | - | 2 | Dec 13, 2023 | |
| NTRA Natera | Initiates: Outperform | n/a | $93.72 | - | 2 | Dec 13, 2023 | |
| WAT Waters | Initiates: Peer Perform | n/a | $315.58 | - | 1 | Dec 13, 2023 | |
| DHR Danaher | Initiates: Peer Perform | n/a | $246.84 | - | 1 | Dec 13, 2023 | |
| A Agilent Technologies | Maintains: Outperform | n/a | $137.52 | - | 2 | Sep 17, 2021 | |
| SOPH SOPHiA GENETICS | Initiates: Outperform | n/a | $5.08 | - | 1 | Aug 17, 2021 | |
| ABSI Absci | Initiates: Market Perform | n/a | $4.98 | - | 1 | Aug 16, 2021 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $10.63 | - | 1 | Aug 9, 2021 | |
| OMIC Singular Genomics Systems | Initiates: Outperform | n/a | $0.40 | - | 1 | Jun 21, 2021 | |
| MASS 908 Devices | Initiates: Outperform | n/a | $5.67 | - | 1 | Jan 12, 2021 | |
| SEER Seer, Inc. | Initiates: Outperform | n/a | $2.16 | - | 1 | Dec 29, 2020 | |
| BNR Burning Rock Biotech | Initiates: Outperform | n/a | $0.76 | - | 1 | Jul 7, 2020 | |
| HOLX Hologic | Upgrades: Outperform | n/a | $75.91 | - | 3 | Jun 30, 2020 | |
| TWST Twist Bioscience | Initiates: Outperform | n/a | $32.01 | - | 1 | Nov 26, 2018 | |
| CDXS Codexis | Initiates: Outperform | n/a | $3.34 | - | 1 | Jun 19, 2018 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | n/a | $36.56 | - | 1 | Mar 28, 2018 | |
| PODD Insulet | Maintains: Outperform | n/a | $173.42 | - | 1 | Feb 22, 2018 | |
| QTRX Quanterix | Initiates: Outperform | n/a | $16.92 | - | 1 | Jan 2, 2018 | |
| CHKP Check Point Software | Downgrades: Market Perform | n/a | $149.47 | - | 1 | Nov 1, 2017 | |
| DXCM DexCom | Maintains: Outperform | n/a | $126.65 | - | 1 | Sep 28, 2017 |
Illumina
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $123.99
Upside: -
Exact Sciences
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $60.54
Upside: -
Thermo Fisher
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $571.25
Upside: -
10x Genomics
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $26.29
Upside: -
Myriad Genetics
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $19.22
Upside: -
Bruker
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $70.09
Upside: -
Revvity
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $101.08
Upside: -
Pacific Biosciences of California
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.76
Upside: -
Qiagen
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $42.68
Upside: -
Avantor
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $24.32
Upside: -
Guardant Health
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $18.58
Upside: -
Natera
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $93.72
Upside: -
Waters
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $315.58
Upside: -
Danaher
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $246.84
Upside: -
Agilent Technologies
Sep 17, 2021
Maintains: Outperform
Price Target: n/a
Current: $137.52
Upside: -
SOPHiA GENETICS
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.08
Upside: -
Absci
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $4.98
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $10.63
Upside: -
Singular Genomics Systems
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.40
Upside: -
908 Devices
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.67
Upside: -
Seer, Inc.
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.16
Upside: -
Burning Rock Biotech
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.76
Upside: -
Hologic
Jun 30, 2020
Upgrades: Outperform
Price Target: n/a
Current: $75.91
Upside: -
Twist Bioscience
Nov 26, 2018
Initiates: Outperform
Price Target: n/a
Current: $32.01
Upside: -
Codexis
Jun 19, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.34
Upside: -
Tandem Diabetes Care
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $36.56
Upside: -
Insulet
Feb 22, 2018
Maintains: Outperform
Price Target: n/a
Current: $173.42
Upside: -
Quanterix
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $16.92
Upside: -
Check Point Software
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $149.47
Upside: -
DexCom
Sep 28, 2017
Maintains: Outperform
Price Target: n/a
Current: $126.65
Upside: -